Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapin combined with Riluzol for the treatment of appetite loss on patients with amyotrophic lateral sklerosis - Olanzapin in treatment of ALS-related appetite loss Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapin comb ...
Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapin combined with Riluzol for the treatment of appetite loss on patients with amyotrophic lateral sklerosis - Olanzapin in treatment of ALS-related appetite loss Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapin comb ...
patients with amyotrophic lateral sclerosis
Trade Name: Zyprexa INN or Proposed INN: OLANZAPINE